TAVI(Transcatheter Aortic Valve Implantation)SAPPHIRENCT07366671
SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation
An observational study of TAVI(Transcatheter Aortic Valve Implantation) and Aortic Valve Disease, run by dr Pim A.L. Tonino at 1 site in Netherlands.
Trial summary
The goal of this observational study is to document which LV-guidewires are used during a TAVI (Transcatheter Aortic Valve Implantation) procedure and how their different functions perform. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- TAVI(Transcatheter Aortic Valve Implantation), Aortic Valve Disease
- How many people
- 300 participants
- Where
- 1 siteNetherlands
- Study dates
- 12 Jan 2026to Mar 2028
- How long will I take part?
- 3 Months
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients eligible for participation in this registry are aged ≥50 years old presenting with symptomatic severe aortic valve stenosis and accepted for transfemoral TAVI procedure after consultation in the Heart team and TAVI team. A pre-procedural CT scan for TAVI sizing is required as standard of care. Both balloon-expandable and self-expandable TAVI platforms are allowed. Valve-in-valve procedures and procedures in bicuspid aortic valve anatomy can be included.
Who may be able to join
- Age ≥ 50 years
- Accepted for transfemoral TAVI procedure by Heart team and TAVI team
- Transfemoral TAVI procedure with balloon-expandable or self-expandable TAVI platform
- Ability to understand and the willingness to provide written informed consent
- Patients scheduled for valve-in-valve procedures can be included
- Patients with bicuspid anatomy can be included
Who cannot join
- Patients planned for a non-transfemoral TAVI procedure
- Extremely horizontal aorta (aortic root angle >70 degrees)
- Extreme tortuosity at the level of the iliofemoral arteries, abdominal and/or thoracic aorta
- Inability to provide informed consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
Catharina Hospital Eindhoven
Eindhoven, North Brabant, 5623EJ
Prof Tonino, 0031-(040)-239 7004, pim.tonino@catharinaziekenhuis.nl
About this study
Official title: SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation; a Prospective Registry (SAPPHIRE)
The goal of this observational study is to document which LV-guidewires are used during a TAVI (Transcatheter Aortic Valve Implantation) procedure and how their different functions perform.
A TAVI procedure is a minimally invasive treatment for aortic stenosis, where a new heart valve is inserted through a blood vessel in the groin. During this procedure, a wire (specifically, an LV-guidewire) is used to place the new heart valve. For this purpose, a regular LV-guidewire or a newer LV-guidewire with extra features, the Savvywire, can be used. All of these wires work well, are safe, and are already used in daily medical practice. Researchers will compare these LV-guidewires to see if the Savvywire adds additional value.
Patients aged 50 or older who undergo a TAVI procedure via the femoral artery (blood vessel in the groin) can participate. Participants will receive the usual care and standard follow-up, only their data will be collected and analyzed.
Read the detailed description
Patients are asked for consent after the TAVI procedure. Procedural data is therefore collected retrospectively, while standard follow-up data (3 months after the procedure) is collected prospectively.
- Medical subject headings
- Aortic Valve Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| SavvyWire | TAVI procedures in which the SavvyWire is used as LV-guidewire. | |
| Other LV-guidwire | TAVI procedures in which another LV-guidewire (i.e. Confida or Safari) is used. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Register which TAVI LV-guidewires are used in contemporary practice
Register which type of TAVI LV-guidewire is used during the TAVI procedure (SavvyWire, Safari, Confida etc).
Measured: At enrollment
To register LV-aortic pressure gradients (mmHg) during each procedural step in the SavvyWire group.
With the SavvyWire, continuous hemodynamic pressure measurements can be performed during the procedure in the aorta and the left ventricle. Pressure measurements (mmHg) during the following procedural steps will be collected: baseline, pacing during predilatation, after predilatation, pacing during TAVI deployment, after TAVI deployment, after equilibration and drift check, after possibele postdilatation.
Measured: Collected during TAVI procedure, extracted at enrollment
To correlate hemodynamic pressure gradient after each procedural step (predilatation, 80% TAVI deployment, postdilatation) to standard baseline CT assessment of valvular calcifications
Measured: At enrollment
Performance of the SavvyWire as LV-guidewire for TAVI device placement
Based on: guidewire kink yes/no, procedural success, complications during and after TAVI procedure and after standard 3 months follow-up (vascular complication, coronary obstruction, conversion to sternotomy, pacemaker, cva, mortality)
Measured: At enrollment + after 3 months of standard follow-up
Performance of the SavvyWire in hemodynamic guidance
Based on: succesfull hemodynamic registrations, drift check (delta between aortic pressure measurement of Savvywire and standard pigtail in aorta used during TAVI procedure), more postdilatation in Savvywire group compared to regular LV guidewire group.
Measured: At enrollment
Pacing performance of the SavvyWire
Based on: pacing frequency, loss-of-capture, the need for RV pacing
Measured: At enrollment
To investigate the potential streamlining effect of the SavvyWire on TAVI workflow
Based on: skin-to-skin time, total contrast volume (mL), amount of radiation exposure (total DAP, total Air Kerma)
Measured: At enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2026
- Study start12 Jan 2026
- Primary completionDec 2027 (estimated)
- Study completionMar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TAVI(Transcatheter Aortic Valve Implantation)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 300 participants (estimated)
- Target duration
- 3 Months
Sponsor and investigators
- Lead sponsor
- dr Pim A.L. Tonino
- Sponsor type
- University, hospital or other
- Collaborators
- Haemonetics Corporation
- Responsible party
- Sponsor-investigator, dr Pim A.L. Tonino, Catharina Ziekenhuis Eindhoven
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07366671
- Sponsor's protocol ID
- SAPPHIRE - nWMO-2025.152
- Other IDs
- Funder
- Acronym
- SAPPHIRE
- Status last verified
- Mar 2026
- First submitted
- 11 Dec 2025
- Last updated
- 11 Mar 2026
- Results posted
- No